GLP-1 medications can be highly effective, but for many, cost and access remain significant barriers
Key areas of research: Growth Hormone Research IGF-1 Research Endocrinology Research GHRH Research Pituitary Function Research Hormonal Signaling Research Metabolic Research Healthy Aging Research Growth Factor Research Neuroendocrinology Research References Growth Hormone-Releasing Hormone and Sermorelin Physiology Growth Hormone-Releasing Hormone Receptor Signaling Pathways References are provided for research context only and do not constitute medical claims
But awareness is the first step through it
This continuous accessibility ensures patients feel supported and valued, fostering a strong sense of community
This information supports a more nuanced provider conversation about dosing strategy, monitoring intensity, and treatment suitability
HR: 0.25, 95% CI: 0.210.30), which was consistent across gender, age group and race and in patients with and without T2DM (Fig